Clinical Trial: A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199777) titled 'A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients' on Sept. 22.

Brief Summary: The objective of this study is to assess the safety, efficacy, and tolerability of SNP318 in patients with DME.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Diabetic Macular Edema DME

Intervention: DRUG: SNP318

Once daily, oral administration

DRUG: Placebo

Once daily, oral administration

Recruitment Status: NOT_YET_RECRUITING

Sponsor: SciNeuro

Disclaimer: Curated by HT Syndication....